Sign in
4

Changes in Ownership

Evofem Biosciences, Inc. Filed Acc 0001209191-15-071843

VP, Pharma Dev & Manufacturing sold 1,000 shares at $12.20 ($12,195)

  • VP, Pharma Dev & Manufacturing acquired 1,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kemmerer Christopher VP, Pharma Dev & Manufacturing 2015-09-18 Option exercise +1,000 $1.34 $1,342 11,848 D
Kemmerer Christopher VP, Pharma Dev & Manufacturing 2015-09-18 Sale −1,000 $12.20 $12,195 10,848 D
Derivatives
Kemmerer Christopher VP, Pharma Dev & Manufacturing 2015-09-18 Option exercise · Stock Option (Right to Buy) −1,000 50,182 D
Open-market sales · 1,000 sh · avg $12.20 · $12,195
Loading xslF345X03/doc4.xml…